1-2 of 2
Maria Gabriela Raso
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B126: Co-clinical trial of novel bispecific anti-HER2 antibody Zanidatamab in Patient-Derived Xenografts

Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Dumbrava, Shubham Pant, Jaffer A Ajani, Paula Pohlmann, V Behrana Jensen, Milind Javle, Jordi Rodon, Funda Meric-Bernstam
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B126.
https://doi.org/10.1158/1535-7163.TARG-23-B126
Published: 01 December 2023
View article titled, Abstract B126: Co-clinical trial of novel bispecific anti-HER2 antibody Zanidatamab in Patient-Derived Xenografts
Journal Articles

Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer

Lauren Averett Byers, F. Christopher Holsinger, Merrill S. Kies, William N. William, Adel K. El-Naggar, J. Jack Lee, Jianhua Hu, Adriana Lopez, Hai T. Tran, Shaoyu Yan, Zhiqiang Du, K. Kian Ang, Bonnie S. Glisson, Maria Gabriela Raso, Ignacio I. Wistuba, Jeffrey N. Myers, Waun-Ki Hong, Vali Papadimitrakopoulou, Scott M. Lippman, John V. Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1755–1763.
https://doi.org/10.1158/1535-7163.MCT-09-1047
Published: 09 June 2010
View article titled, Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer
Open the PDF for Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer in another window